IQI
GMAB icon

Integrated Quantitative Investments’s Genmab GMAB Stock Holding History

Integrated Quantitative Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
90,718
+54,363
+150% +$1.44M 0.41% 58
2026
Q1 		$975K Buy
+36,355
New +$1.09M 0.18% 210

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrated Quantitative Investments's GMAB Position: Q2 2026 in Review

Integrated Quantitative Investments increased its Genmab (GMAB) stake by 150% in Q2 2026, buying an estimated $1.44M and bringing the position to 90,718 shares worth $2.49M. The position accounts for 0.41% of the portfolio, ranked #58.

Integrated Quantitative Investments first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Integrated Quantitative Investments held 90,718 shares of Genmab worth $2.49M as of Q2 2026.
  • Integrated Quantitative Investments bought 54,363 Genmab shares in Q2 2026, an estimated $1.44M.
  • Genmab made up 0.41% of Integrated Quantitative Investments's portfolio in Q2 2026, its #58 holding.
  • Integrated Quantitative Investments first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.